Mark Morrison

Professor Mark Morrison is an Affiliate Professor at the School of Chemistry and Molecular Biosciences, University of Queensland, and holds roles as Chair & Group Leader of Metagenomics at the Frazer Institute within the Faculty of Health, Medicine and Behavioural Sciences. His research focuses on clinical microbiology, gastroenterology, and the microbiome’s role in diseases like inflammatory bowel disease (IBD) and diabetes. He has extensive academic qualifications, including a Bachelor of Science from the University of New South Wales, a Master’s from James Cook University, and a PhD from the University of Illinois.

• Education:
  • Bachelor of Science, University of New South Wales
  • Masters (Research) of Science, James Cook University
  • Doctor of Philosophy, University of Illinois

His research interests span microbiome-driven health and disease mechanisms, particularly in gut-brain interactions, mucosal microbiota dynamics, and translational therapies. Over 390 works include studies on dietary FODMAP effects, microbiome-based IBD diagnostics, and SCFA therapy for diabetes. He leads interdisciplinary grants on microbiome manipulation and has advised numerous PhD students on topics like Crohn’s disease, archaeal biodiversity, and immune modulation.

His recent articles highlight microbiota roles in SIBO, anastomotic leaks, and probiotic efficacy. While no explicit awards are cited, his contributions to gut microbiome science are recognized through active research collaborations and funding. He actively supervises students and chairs teams advancing metagenomics and clinical applications.